Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogenes and erythroid differentiation

T Metz1

  • 1Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Victoria, Australia.

Seminars in Cancer Biology
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracting microplastic decay rates from field data.

Scientific reports·2022
Same author

Multicomponent superconducting order parameter in UTe<sub>2</sub>.

Science (New York, N.Y.)·2021
Same author

Quantification of microplastics: Which parameters are essential for a reliable inter-study comparison?

Marine pollution bulletin·2020
Same author

Pregnancy with Loeys-Dietz: care informed by case series.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Demethylation of the hypoxia induction factor 1 binding site of GPX3 at excess blood ammonia in propionic acidemia.

Clinical biochemistry·2019
Same author

[Superficial acral fibromyxoma in a sub-matricial location: An unusual variant].

Annales de dermatologie et de venereologie·2014
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
Same journal

Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction.

Seminars in cancer biology·2026
See all related articles

Acute erythroleukemia involves oncogenes hijacking normal self-renewal in erythroid progenitors. Growth hormones can also induce this self-renewal, suggesting oncogenes exploit existing pathways rather than causing abnormal growth.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Committed erythroid progenitors are the cellular targets of retroviruses causing acute erythroleukemia.
  • These progenitors normally undergo limited cell divisions during terminal differentiation into erythrocytes.
  • Sustained self-renewal in leukemic cells was previously attributed to abnormal, oncogene-induced effects.

Purpose of the Study:

  • To investigate the mechanism by which oncogenes induce self-renewal in erythroid progenitors.
  • To test the hypothesis that oncogenes exploit the inherent self-renewal capacity of these cells.

Main Methods:

  • Analysis of avian and murine retroviruses inducing acute erythroleukemia.
  • Study of normal avian erythroid progenitors' response to growth and differentiation hormones.

Related Experiment Videos

  • Comparison of self-renewal induced by oncogenes versus hormonal stimulation.

    • Main Results:

    • Certain hormone combinations (TGF-alpha and estradiol) induce extensive self-renewal in normal erythroid progenitors.
    • This hormone-induced self-renewal mirrors the sustained proliferation observed in oncogene-transformed leukemic cells.
    • Findings challenge the notion that oncogenes solely reprogram cells to abnormal growth.

    Conclusions:

    • Leukemia-inducing oncogenes likely exploit the natural self-renewal capacity of committed erythroid progenitors.
    • This perspective reframes oncogene action in erythroleukemia, emphasizing the hijacking of normal cellular processes.
    • Further research into these pathways could reveal novel therapeutic targets for acute erythroleukemia.